GIGail Ishiyama

Gail Ishiyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gail Ishiyama has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Histopathologic Considerations for Indication of Cochlear Implant for Patients With Vestibular Schwannoma

    by Shinya Ohira, Ivan A. Lopez, Maya Harary, Maureen Laufer, Gail Ishiyama, Gregory P. Lekovic, Akira Ishiyama

    Objective: Predicting cochlear implant (CI) outcomes in patients with vestibular schwannoma (VS) is challenging, even when the cochlear nerve remains anatomically intact. This study examined how cochlear and neural pathology relate to premortem audiometric findings, pure-tone average (PTA) and speech discrimination score (SDS), to explore histopathologic conditions that may be relevant to CI candidacy. Methods: Temporal bones labeled as “acoustic neuroma” were selected from the House Ear Institute Temporal Bone Registry. Twenty-eight patients (34 ears) with well-preserved cochlear structures were included. Clinical data, including audiometry, surgical history, and surgical approach, were reviewed. Histologic analysis assessed residual tumor, fundal involvement, and the status of cochlear hair cells and spiral ganglion cells (SGCs). Pathology was correlated with clinical and audiometric features. Results: Among 34 specimens from 28 patients, 7 were from nonsurgical cases and 27 from surgical cases. In cases with preserved hearing (PTA ≤60 dB or SDS ≥60%), spiral ganglion cell (SGC) counts exceeded 20,000, and hair cells were well preserved. Cases with severe PTA elevation commonly showed hair cell injury, yet SGCs remained partially preserved. In contrast, reduced SDS was consistently associated with SGC loss. After a translabyrinthine approach, SGCs and hair cells were nearly absent within 3 to 27 months in most cases, and cochlear ossification was observed in cases surviving beyond 50 months. In all cases with tumor extension into the fundus of the internal auditory canal, hearing was completely lost, and both hair cells and SGCs showed severe degeneration. Conclusion: SDS may parallel SGC status in VS, possibly more closely than PTA. These findings suggest that early tumor removal before fundal extension and preservation of the cochlear nerve may be associated with cochlear and neural integrity, which could be relevant for future CI candidacy.

  • Increased Adrenergic Receptor Expression in Meniere Disease

    by Adam Y. Xiao, Achilles Kanaris, Masanori Ishii, Gregory P. Lekovic, Ivan A. Lopez, Gail Ishiyama, Akira Ishiyama

    Hypothesis: There is increased expression of adrenergic receptors in the vestibular end organs of Meniere disease. Background: Meniere disease (MD) is an inner ear condition characterized by episodic vertigo, hearing loss, tinnitus, and aural fullness. It is believed to be due to an imbalance in inner ear fluid, often leading to hydrops; however, the exact mechanism is unclear. Pupillometry data have suggested a role for autonomic dysfunction, specifically sympathetic hyperactivity, but few studies have investigated the molecular pathways involved in this. Methods: Vestibular end organs from patients undergoing labyrinthectomy for MD (n=6), as well as control specimens (n=3) from patients with vestibular schwannoma undergoing translabyrinthine resection, were collected and processed for RNA in situ hybridization using the RNAscope Multiplex Fluorescent V2 Assay with probes for β 1 -, β 2 -, and α 1a -adrenergic receptors (AR). Positive and negative control experiments were also performed for quality control. Immunofluorescence was used to characterize protein expression of α 1a -AR and to identify vestibular hair cells (VHC) in the sensory epithelium (Myosin VIIa). Results: There is increased expression of α 1a -AR transcripts in MD utricles compared with control. This appears to be concentrated in the sensory epithelium VHC, confirmed with MyoVIIa positivity, although expression can be seen in the stroma as well. This was further confirmed with immunofluorescence, demonstrating increased expression in MD. There is also transcriptional expression of β 2 -AR with no difference between the 2 groups. Conclusions: There are limited molecular studies investigating the pathogenesis of MD, especially those utilizing human surgical tissue. This is the first study to demonstrate increased expression of α 1a -AR both at the transcriptional and protein levels in MD compared with controls. These results may help explain the mechanism behind sympathetic hyperactivity and guide future therapies.

  • Expression of Brain-Derived Neurotrophic Factor in Human Spiral Ganglia Neurons after Cochlear Implantation

    by Emily C. Wong, Ivan A. Lopez, Akira Ishiyama, Gail Ishiyama

    Background: Brain-derived neurotrophic factor (BDNF) is an important factor in the development and neuroprotection of afferent auditory pathways. In this study, we investigated the expression of BDNF in the afferent auditory pathway after cochlear implantation (CI), hypothesizing that electrical stimulation after CI stimulates BDNF expression in the afferent auditory pathway. Methods: Archival human temporal bones from eight patients with a history of CI and five patients with normal hearing (ages 65–93 years old) were studied. Temporal bone specimens were immunoreacted with rabbit polyclonal antibodies against BDNF and mouse monoclonal antibodies against pan-neurofilaments. In cases of unilateral CI, the BDNF expression was compared with the contralateral unimplanted ear and normal temporal bones without hearing loss. Results: BDNF immunoreactivity (IR) localized to the spiral ganglion neurons (SGNs) somata and the surrounding satellite cells. BDNF-IR in the spiral ganglia was similar in the apical, middle, and basal hook regions. Neurofilament IR localized to SGN nerve fibers in both implanted and unimplanted cochleae. BDNF-IR in the SGN and satellite cells was significantly increased in the implanted specimens compared with the unimplanted specimens (p < 0.05) and the normal hearing specimens (p < 0.05). BDNF-IR expression was similar in the unimplanted cochlea and in the normal cochlea. BDNF protein expression was increased despite complete loss of the organ of Corti hair cells and supporting cells. Even in the cases of CI with a 6-mm first-generation electrode, BDNF expression was upregulated throughout the cochlea. Conclusions: BDNF expression in the SGN appears to be upregulated by the electrical stimulation from CI. This study provides evidence that the electrical stimulation from CI may stimulate the expression of BDNF, playing a neuroprotective role in the rehabilitation of hearing in the deafened ear.


  • Open Access

    Archival Human Temporal Bone: Anatomical and Histopathological Studies of Cochlear Implantation

    by Paul Ishiyama, Gail Ishiyama, Ivan A. Lopez, Akira Ishiyama

    Since being FDA approved in 1984, cochlear implantation has been used successfully to restore hearing in those with severe to profound hearing loss with broader applications including single-sided deafness, the use of hybrid electroacoustic stimulation, and implantation at all extremes of age. Cochlear implants have undergone multiple changes in the design aimed at improving the processing technology, while simultaneously minimizing the surgical trauma and foreign body reaction. The following review examines the human temporal bone studies regarding the anatomy of the human cochlea and how the anatomy relates to cochlear implant design, the factors related to complications after implantation, and the predictors of new tissue formation and osteoneogenesis. Histopathological studies are reviewed which aim to understand the potential implications of the effects of new tissue formation and inflammation following implantation.


  • Open Access

    Cochlear Meniere's: A Distinct Clinical Entity With Isolated Cochlear Hydrops on High-Resolution MRI?

    by Jose E. Alonso, Gail P. Ishiyama, Rance J. T. Fujiwara, Nancy Pham, Luke Ledbetter, Akira Ishiyama

    Objective: Describe the clinical characteristics of patients with isolated cochlear endolymphatic hydrops (EH).Study design: Clinical case series.Setting: Tertiary Neurotology referral clinic.Patients: All subjects presenting to a University Neurotology clinic during a 1-year period from July 2015 until August 2016 who had isolated cochlear EH on MRI. Patients with a history of temporal bone surgery prior to the MRI were excluded.Intervention: High-resolution delayed-intravenous contrast MRI.Main outcome measures: Audiometric and vestibular testing, clinical history analysis.Results: 10 subjects demonstrated isolated, unilateral cochlear hydrops on MRI. None of these patients met the criteria for Meniere's disease. Mean age of the group was 66.4 years and most were males (70%). Unilateral aural fullness (70%), tinnitus (80%), and hearing loss (90%) were frequently observed. Only one patient presented with unsteadiness (10%) and one patient had a single isolated spell of positional vertigo 1 month prior to the MRI (10%) but no further vertigo spells in the 4 years following the MRI. The mean PTA was 37.8 dB which was significantly decreased from the non-affected ear with PTA of 17.9 (p < 0.001). One patient developed vertiginous spells and unsteadiness 4 years after initial presentation and a repeat MRI revealed progression to utricular, saccular and cochlear hydrops. Vestibular testing was obtained in five patients with one patient presenting with 50% caloric paresis and all others normal. The most common treatment tried was acetazolamide in seven patients with 86% reporting subjective clinical improvement. Two out of the 10 patients had a history of migraine (20%).Conclusions: Patients with MRI exhibiting isolated cochlear EH present with predominantly auditory symptoms: mild to moderate low-frequency hearing loss, aural fullness, tinnitus without significant vertigo. Isolated cochlear hydrops is more common in males, average age in mid-60's and there is a low comorbidity of migraine headaches. This contrasts significantly with patients with isolated saccular hydrops on MRI from our prior studies. We believe that isolated cochlear EH with hearing loss but no vertigo is distinct from Meniere's disease or its variant delayed endolymphatic hydrops. We propose that cochlear Meniere's disease represents a distinct clinical entity that could be a variant of Meniere's disease.


  • Selected Otologic Disorders Causing Dizziness

    by Gail Ishiyama

    Cholesteatoma, Ramsay Hunt syndrome, enlarged vestibular aqueduct syndrome, and autoimmune inner ear disease including Cogan syndrome. RECENT FINDINGS The recent data on modern imaging techniques with three-dimensional delayed IV contrast in Ménière disease, findings on the clinical and testing parameters to diagnose semicircular canal dehiscence and barotrauma, and clinical findings in Ramsay Hunt syndrome, cholesteatoma, and enlarged vestibular aqueduct syndrome are discussed in the article. The most recent findings on the treatment and evaluation of autoimmune inner ear disease and Cogan syndrome are also covered. SUMMARY This article discusses the common clinical otologic entities in patients who may present to the neurologist for vertigo, and it can be used as a guide in the diagnosis of these conditions with the use of auditory, vestibular, and imaging results....


  • Isolated Saccular Hydrops on High-resolution MRI Is Associated With Full Spectrum Menière's Disease

    by Anne K. Maxwell, Gail Ishiyama, Stellios Karnezis, Akira Ishiyama

    Objective: To describe the clinical presentation of patients with isolated saccular endolymphathic hydrops (EH) detected. Study Design: Clinical case series. Setting: University-based tertiary referral center. Patients: All subjects presenting with vertigo or hearing loss who had isolated saccular EH detected. Intervention: High-resolution delayed-contrast magnetic resonance imaging (MRI) conducted between November 2015 and November 2016. Main Outcome Measures: Audiovestibular testing results and analysis of clinical histories. Results: Isolated saccular EH was detected in 18 subjects. Sixteen met criteria for definite Menière's disease (MD, n = 12) or delayed endolymphatic hydrops (DEH, n = 4). One had a history of sudden sensorineural hearing loss (SSNHL) and 3 years after MRI developed recurrent vertigo characteristic of DEH. One patient had a history of atypical DEH (Tumarkin falls without vertigo following SSNHL). Four patients had Tumarkin falls. Most (83%) demonstrated mild-to-severe low-frequency fluctuating loss, and six (33.3%) had a history of ipsilateral sudden profound SNHL. Nine of the 17 (53%) patients tested had an ipsilateral caloric paresis ranging from 26 to 67%. Ipsilateral vestibular-evoked myogenic potentials showed reduced or absent responses in 5 of the 17 tested (29%). Conclusions: The full spectrum of MD may be associated with saccular hydrops. We propose that MD and DEH often begin in the saccule, and MRI may provide clues to the pathophysiology of MD. Saccular hydrops was present in one patient with SSNHL who did not develop vertigo spells until 3 years after MRI, indicating that saccular hydrops may be the first manifestation of MD or DEH.


  • Human Temporal Bone Study of Vestibular Histopathology in Cochlear Implant Patients With Cochlear Hydrops

    by Brooke M. Su-Velez, Ivan A. Lopez, Akira Ishiyama, Gail Ishiyama

    Hypothesis: Endolymphatic hydrops (EH) associated with cochlear implantation are associated with vestibular dysfunction. Background: Vestibular dysfunction is a known risk after cochlear implantation (CI). CI has been shown to cause cochlear hydrops due to fibrosis surrounding the ductus reuniens. However, the association of cochlear hydrops with vestibular hydrops and the relationship to vestibular symptoms remain unknown. Methods: Histopathological analysis and clinical evaluation of the vestibular end organs of 17 human temporal bones (HTB)s exhibiting cochlear hydrops from 15 CI recipients. Results: Eight of 15 patients with cochlear hydrops due to CI had complaints of dizziness, vertigo, or imbalance following CI. In all 17 HTBs with cochlear hydrops, there was fibrosis, atrophy, or obstruction of the ductus reuniens, and all had straight electrode CI via cochleostomy. In one of the eight reporting postoperative dizziness, labyrinthitis ossificans was deemed causative. Six of the seven remaining patients had EH of both the saccule and utricle. Fifteen of 17 HTBs (88.2%) had saccular EH. In contrast, 8 of 17 HTBs (47.0%) in 7 patients had utricular EH, of which 6 patients had postoperative vertigo spells. It seems that hydrops of the utricle closely corresponds to postoperative vertigo spells and vestibular complaints. Conclusion: Implantation of the CI, when complicated by ductus reuniens fibrosis, may cause both cochlear hydrops and vestibular endolymphatic hydrops. Hydrops of the vestibular periphery when involving the utricle seems to be more likely associated with disabling vertigo symptoms. This study supports the round window technique of insertion rather than cochleostomy.


  • Sudden hearing loss after cialis (tadalafil) use: A unique case of cochlear hydrops

    by Jacob L. Wester, Gail Ishiyama, Stellios Karnezis, Akira Ishiyama

    We discuss a unique case of sudden sensorineural hearing loss after Cialis (tadalafil) use, a phosphodiesterase 5 (PDE5) inhibitor, and the implication of ipsilateral cochlear hydrops seen on magnetic resonance imaging (MRI). We report a case of a 53‐year‐old male with unilateral low‐frequency sudden sensorineural hearing loss (SSNHL) after ingestion of tadalafil. The SSNHL occurred 1 day after ingestion and was associated with aural fullness and tinnitus. There were no symptoms of vertigo. He received oral prednisone immediately after the onset of hearing loss without improvement. Delayed intravenous contrast‐enhanced three‐dimensional Fluid‐attenuated inversion recovery MRI revealed ipsilateral dilation of the cochlear duct without any hydronic change in the vestibular system. Acetazolamide therapy was initiated, and his symptoms improved. A posttreatment audiogram revealed an increase in threshold of 15 dB. To the best of our knowledge, this is the first case of cochlear hydrops visualized on imaging after a PDE5 inhibitor induced SSNHL. Tadalafil and other PDE5 inhibitors have a known association with SSNHL. Despite several proposed mechanisms, there is inconclusive evidence of a causal relationship. Our presented case suggests that cochlear hydrops may be one possible mechanism of PDE5 inhibitor–associated SSNHL. MRI should be considered in the evaluation of such patients who do not respond to oral steroids as initial treatment. Laryngoscope, 2615–2618, 2018


  • Open Access

    Oxidative Stress in the Blood Labyrinthine Barrier in the Macula Utricle of Meniere’s Disease Patients

    by Gail Ishiyama, Jacob Wester, Ivan A. Lopez, Luis Beltran-Parrazal, Akira Ishiyama

    The blood labyrinthine barrier (BLB) is critical in the maintenance of inner ear ionic and fluid homeostasis. Recent studies using imaging and histopathology demonstrate loss of integrity of the BLB in the affected inner ear of Meniere’s disease (MD) patients. We hypothesized that oxidative stress is involved in the pathogenesis of BLB degeneration, and to date there are no studies of oxidative stress proteins in the human BLB. We investigated the ultrastructural and immunohistochemical changes of the BLB in the vestibular endorgan, the macula utricle, from patients with MD (n = 10), acoustic neuroma (AN) (n = 6) and normative autopsy specimens (n = 3) with no inner ear disease. Each subject had a well-documented clinical history and audiovestibular testing. Utricular maculae were studied using light and transmission electron microscopy and double labeling immunofluorescence. Vascular endothelial cells (VECs) were identified using isolectin B4 (IB4) and glucose-transporter-1 (GLUT-1). Pericytes were identified using alpha smooth muscle actin (αSMA) and phalloidin. IB4 staining of VECS was consistently seen in both AN and normative. In contrast, IB4 was nearly undetectable in all MD specimens, consistent with the significant VEC damage confirmed on transmission electron microscopy. GLUT-1 was present in MD, AN, and normative. αSMA and phalloidin were expressed consistently in the BLB pericytes in normative, AN specimen, and Meniere’s specimens. Endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS), and nitrotyrosine were used as markers of oxidative stress. The VECs of the BLB in Meniere’s had significantly higher levels of expression of iNOS and nitrotyrosine compared with normative and AN specimen. eNOS-IF staining showed similar patterns in normative and Meniere’s specimens. Microarray-based gene expression profiling confirmed upregulation of iNOS mRNA from the macula utricle of Meniere’s patients compared with AN. Nitrotyrosine, a marker recognized as a hallmark of inflammation, especially when seen in association with an upregulation of iNOS, was detected in the epithelial and stromal cells in addition to VECs in MD. Immunohistochemical and ultrastructural degenerative changes of the VEC suggest that these cells are the primary targets of oxidative stress, and pericyte pathology including degeneration and migration, likely also plays a role in the loss of integrity of the BLB and triggering of inflammatory pathways in MD. These studies advance our scientific understanding of oxidative stress in the human inner ear BLB and otopathology.